Other studies have shown that blocking RANTES/CCL5 in vivo significantly increases the titers of respiratory syncytial virus in the lungs of infected mice, and this is associated with reduced T cell recruitment [48] and heightened lung disease. This evidence concerns the gene CCL5 and lung disorder.